novel inhibitor of FGFR 1 , 2 , 3 , and 4 , inhibits the growth of FGF 19-expressing hepatocellular carcinoma

semanticscholar(2016)

引用 0|浏览0
暂无评分
摘要
ASP5878, a novel inhibitor of FGFR 1, 2, 3, and 4, inhibits the growth of FGF19expressing hepatocellular carcinoma Takashi Futami, Hidetsugu Okada, Rumi Kihara, Tatsuya Kawase, Ayako Nakayama, Tomoyuki Suzuki, Minoru Kameda, Nobuaki Shindoh, Tadashi Terasaka, Masaaki Hirano, and Sadao Kuromitsu Drug Discovery Research, Astellas Pharma Inc., Ibaraki, Japan Running title: ASP5878, a novel FGFR1, 2, 3, and 4 inhibitor for HCC
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要